Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.49 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.49 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.45 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | GALR3 | O60755 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30477373 | 0.87 | ADRA2C (0.47) | EGLN2PTGDR2ADRA2CCYP19A1KCNA5 | |
| SCHEMBL15856515 | 0.86 | CYP19A1 (0.55) | EGLN2PTGDR2ADRA2CCYP19A1KCNA5 | |
| SCHEMBL2154388 | 0.85 | EGLN2 (0.52) | EGLN2ALDH1A1MEN1KMT2ACYP2A6 | |
| SCHEMBL14743162 | 0.84 | DPP4 (0.37) | EGLN2PTGDR2ALDH1A1KDM4EHPGD | |
| SCHEMBL27751348 | 0.84 | PTGDR2 (0.50) | PTGDR2ADRA2CCYP19A1KCNA5ALDH1A1 | |
| SCHEMBL28273598 | 0.84 | ADRA2C (0.44) | EGLN2PTGDR2ADRA2CCYP19A1KCNA5 | |
| SCHEMBL4455682 | 0.83 | TSHR (0.48) | PTGDR2ADRA2CCYP19A1KCNA5ALDH1A1 | |
| SCHEMBL5697352 | 0.82 | TSHR (0.50) | PTGDR2ADRA2CCYP19A1ALDH1A1KDM4E | |
| SCHEMBL5307030 | 0.82 | TSHR (0.50) | PTGDR2ADRA2CCYP19A1ALDH1A1KDM4E | |
| SCHEMBL31364597 | 0.82 | PTGDR2 (0.40) | EGLN2PTGDR2ADRA2CCYP19A1KCNA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116367571-A | Electroluminescent device, method of manufacturing the same, display apparatus including the same, and layered structure | 三星电子株式会社 | 2023-06-30 | — | — | CN | disclosed |
| CN-113671068-B | Method for analyzing environmental pollutant targeted exposure group in blood plasma and application thereof | 暨南大学 | 2023-01-24 | — | — | CN | disclosed |
| EP-1638551-B1 | IMMUNOSUPPRESSANT COMPOUNDS AND COMPOSITIONS | IRM LLC (BM) | 2011-12-21 | — | — | EP | disclosed |
| CN-1787817-B | Immunosuppressant compounds and compositions | IRM LLC | 2011-09-07 | — | — | CN | disclosed |
| EP-1638551-A4 | IMMUNOSUPPRESSANT COMPOUNDS AND COMPOSITIONS | IRM LLC (BM) | 2008-12-31 | — | — | EP | disclosed |
| CN-1787817-A | Immunosuppressant compounds and compositions | IRM LLC (BM) | 2006-06-14 | — | — | CN | disclosed |
| US-7060697-B2 | Immunosuppressant compounds and compositions | IRM LLC (BM) | 2006-06-13 | — | — | US | disclosed |
| EP-1638551-A2 | IMMUNOSUPPRESSANT COMPOUNDS AND COMPOSITIONS | IRM LLC (BM) | 2006-03-29 | — | — | EP | disclosed |
| US-20050014724-A1 | Immunosuppressant compounds and compositions | IRM LLC, A DELAWARE LIMITED LIABILITY COMPANY (BM) | 2005-01-20 | — | — | US | disclosed |
| WO-2004103309-A2 | IMMUNOSUPPRESSANT COMPOUNDS AND COMPOSITIONS | IRM LLC (BM) | 2004-12-02 | — | — | WO | disclosed |
| EP-0641372-B1 | LIQUID CRYSTALLINE LIGHT MODULATING DEVICE & MATERIAL | UNIV KENT STATE OHIO (US) | 1999-04-21 | — | — | EP | disclosed |
| EP-0582656-B1 | CRYSTALLINE LIGHT MODULATING DEVICE AND MATERIAL | UNIV KENT STATE OHIO (US) | 1999-04-07 | — | — | EP | disclosed |
| US-5695682-A | Liquid crystalline light modulating device and material | KENT STATE UNIVERSITY (US) | 1997-12-09 | — | — | US | disclosed |
| US-5691795-A | Polymer stabilized liquid crystalline light modulating device and material | KENT STATE UNIVERSITY (US) | 1997-11-25 | — | — | US | disclosed |
| US-5437811-A | Liquid crystalline light modulating device and material | KENT STATE UNIVERSITY (US) | 1995-08-01 | — | — | US | disclosed |
| EP-0641372-A1 | LIQUID CRYSTALLINE LIGHT MODULATING DEVICE & MATERIAL | KENT STATE UNIVERSITY (US) | 1995-03-08 | — | — | EP | disclosed |
| EP-0582656-A4 | — | — | 1994-04-13 | — | — | EP | disclosed |
| EP-0582656-A1 | CRYSTALLINE LIGHT MODULATING DEVICE AND MATERIAL | KENT STATE UNIVERSITY (US) | 1994-02-16 | — | — | EP | disclosed |
| WO-1993023496-A1 | LIQUID CRYSTALLINE LIGHT MODULATING DEVICE & MATERIAL | KENT STATE UNIVERSITY (US) | 1993-11-25 | — | — | WO | disclosed |
| WO-1992019695-A2 | CRYSTALLINE LIGHT MODULATING DEVICE AND MATERIAL | KENT STATE UNIVERSITY (US) | 1992-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014724-A1 | Immunosuppressant compounds and compositions | ICOS, EDNRA, NFATC1 | EGLN2 2775/4885PTGDR2 324/4885ADRA2C 2017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.